Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Maureen M J, Guichelaar"'
Autor:
Anna E. C. Stoelinga, Maarten E. Tushuizen, Wilbert B. van den Hout, Mar D. M. Rodriguez Girondo, Elsemieke S. de Vries, Amar D. Levens, Dirk-Jan A. R. Moes, Tom J. G. Gevers, Suzanne van der Meer, Hans T. Brouwer, Hendrik J. M. de Jonge, Ynte S. de Boer, Ulrich H. W. Beuers, Adriaan J. van der Meer, Aad P. van den Berg, Maureen M. J. Guichelaar, Joost P. H. Drenth, Bart van Hoek, on behalf of the Dutch Autoimmune Hepatitis Group
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Autoimmune hepatitis (AIH) is a rare, chronic inflammatory disease of the liver. The treatment goal is reaching complete biochemical response (CR), defined as the normalisation of aspartate and alanine aminotransferases and immuno
Externí odkaz:
https://doaj.org/article/e9871b3711e44943a5adbb67b77352b2
Autor:
Romée J. A. L. M. Snijders, Anna E. C. Stoelinga, Tom J. G. Gevers, Simon Pape, Maaike Biewenga, Robert C. Verdonk, Hendrik J. M. de Jonge, Jan Maarten Vrolijk, Sjoerd F. Bakker, Thomas Vanwolleghem, Ynto S. de Boer, Martine A. M. C. Baven Pronk, Ulrich H. W. Beuers, Adriaan J. van der Meer, Nicole M. F. van Gerven, Marijn G. M. Sijtsma, Bart J. Verwer, Ingrid A. M. Gisbertz, Maartje Bartelink, Floris F. van den Brand, Kerem Sebib Korkmaz, Aad P. van den Berg, Maureen M. J. Guichelaar, Khalida Soufidi, Amar D. Levens, Bart van Hoek, Joost P. H. Drenth, on behalf of the Dutch Autoimmune Hepatitis Working Group
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-13 (2022)
Abstract Background Currently, the standard therapy for autoimmune hepatitis (AIH) consists of a combination of prednisolone and azathioprine. However, 15% of patients are intolerant to azathioprine which necessitates cessation of azathioprine or cha
Externí odkaz:
https://doaj.org/article/94c4694744e64d888bdd6fba2110a79f
Publikováno v:
Hepatology. 59:1668-1670
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3da17a3471c98f1696afb1bf510b3e7
https://doi.org/10.1002/hep.27058
https://doi.org/10.1002/hep.27058
Publikováno v:
Liver Transplantation. 10:638-647
Bone loss occurs early after orthotopic liver transplantation (OLT) in all liver transplant recipients and leads to postoperative fractures, especially in cholestatic patients with the lowest bone mass. Little is known about the underlying changes in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5453fdbc84cc2be52c38796fa298ce2c
https://doi.org/10.1002/lt.20160
https://doi.org/10.1002/lt.20160
Publikováno v:
Journal of Bone and Mineral Research. 18:2190-2199
Thirty-three patients with cholestatic liver disease underwent histomorphometric assessment of paired bone biopsy specimens at time of orthotopic liver transplantation (OLT) and 4 months thereafter. At 4 months after OLT, bone metabolism improved, wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e513bd8bce38a4856971725a8f8b91c
https://doi.org/10.1359/jbmr.2003.18.12.2190
https://doi.org/10.1359/jbmr.2003.18.12.2190
Autor:
Maureen M. J. Guichelaar, Joanne T. Benson, Ruud A.F. Krom, Michael Malinchoc, Russell H. Wiesner, Michael Charlton
Publikováno v:
American Journal of Transplantation. 3:885-890
Non-anastomotic biliary stricture (NAS) formation is a major complication of liver transplantation. We prospectively determined the time to development of responsiveness to treatment, and clinical outcomes following NAS formation. In addition, an ext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8181cd7aac70b396b3cb1e8739c907ac
https://doi.org/10.1034/j.1600-6143.2003.00165.x
https://doi.org/10.1034/j.1600-6143.2003.00165.x
Publikováno v:
Hepatology. 36:895-903
Despite the clinical importance of cholestatic osteopenia, little is known about its pathophysiologic mechanism. By tetracycline-labeled histomorphometric analysis of bone biopsies taken at the time of liver transplantation, we prospectively evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61a25443a37eeeb5e8e5528393ae1788
https://doi.org/10.1053/jhep.2002.36357
https://doi.org/10.1053/jhep.2002.36357
Publikováno v:
Hepatology (Baltimore, Md.). 59(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8cbc2958ecce654b2fd9c42b1061c095
https://pubmed.ncbi.nlm.nih.gov/23996808
https://pubmed.ncbi.nlm.nih.gov/23996808
Autor:
Michael Malinchoc, Michael Olivier, Anuradha Krishnan, Maureen M. J. Guichelaar, Schuyler O. Sanderson, Samer Gawrieh, Kymberly D. Watt, Kimberly Viker, Michael G. Sarr, Michael Charlton, James M. Swain
Publikováno v:
Obesity.
Objective: Allelic variation (rs738409CG) in adiponutrin (patatin-like phospholipase domain-containing protein 3, PNPLA3) has been associated with hepatic steatosis and liver fibrosis. The physiologic impact of the PNPLA3 G allele may be exacerbated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23387df5c1ece61689171b07f8a94554
https://doi.org/10.1002/oby.20327
https://doi.org/10.1002/oby.20327
Autor:
Nicole M F, van Gerven, Bart J, Verwer, Birgit I, Witte, Bart, van Hoek, Minneke J, Coenraad, Karel J, van Erpecum, Ulrich, Beuers, Henk R, van Buuren, Rob A, de Man, Joost P H, Drenth, Jannie W, den Ouden, Robert C, Verdonk, Ger H, Koek, Johannes T, Brouwer, Maureen M J, Guichelaar, Chris J J, Mulder, Karin M J, van Nieuwkerk, Gerd, Bouma, M A M T, Verhagen
Publikováno v:
van Gerven, N M F, Verwer, B J, Witte, B I, van Hoek, B, Coenraad, M J, van Erpecum, K J, Beuers, U, van Buuren, H R, de Man, R A, Drenth, J P H, den Ouden, J W, Verdonk, R C, Koek, G H, Brouwer, J T, Guichelaar, M M J, Mulder, C J J, van Nieuwkerk, C M J & Bouma, G 2013, ' Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission ', Journal of Hepatology, vol. 58, no. 1, pp. 141-147 . https://doi.org/10.1016/j.jhep.2012.09.009
Journal of Hepatology, 58, 141-7
Journal of Hepatology, 58(1), 141-147. Elsevier Science
Journal of Hepatology, 58(1), 141-147
Journal of Hepatology, 58(1), 141-147. Elsevier
Journal of Hepatology, 58(1), 141-147. ELSEVIER SCIENCE BV
Journal of hepatology, 58(1), 141-147. Elsevier
Journal of Hepatology, 58, 1, pp. 141-7
Journal of Hepatology, 58, 141-7
Journal of Hepatology, 58(1), 141-147. Elsevier Science
Journal of Hepatology, 58(1), 141-147
Journal of Hepatology, 58(1), 141-147. Elsevier
Journal of Hepatology, 58(1), 141-147. ELSEVIER SCIENCE BV
Journal of hepatology, 58(1), 141-147. Elsevier
Journal of Hepatology, 58, 1, pp. 141-7
Background & Aims: Current treatment strategies in autoimmune hepatitis (AIH) include long-term treatment with corticosteroids and/or azathioprine. Here we determined the risk of relapse after drug withdrawal in patients in long-term remission and fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6c908ca065c308833e67dd137bd1504
https://hdl.handle.net/1887/96970
https://hdl.handle.net/1887/96970
